RNA Interference Technology: From Basic Science to Drug Development
by Edited by Krishnarao Appasani , Foreword by Andrew Fire , Marshall NirenbergEdition: Revised
Format: Paperback
Pub. Date: 2011-08-11
Publisher(s): Cambridge University Press
Other versions by this Author
List Price: $74.89
Buy New
Usually Ships in 8 - 10 Business Days.
$71.32
Rent Textbook
Select for Price
Used Textbook
We're Sorry
Sold Out
eTextbook
We're Sorry
Not Available
How Marketplace Works:
- This item is offered by an independent seller and not shipped from our warehouse
- Item details like edition and cover design may differ from our description; see seller's comments before ordering.
- Sellers much confirm and ship within two business days; otherwise, the order will be cancelled and refunded.
- Marketplace purchases cannot be returned to eCampus.com. Contact the seller directly for inquiries; if no response within two days, contact customer service.
- Additional shipping costs apply to Marketplace purchases. Review shipping costs at checkout.
Summary
RNA Interference (RNAi) technology has rapidly become one of the key methods used in functional genomics. RNAi is used to block the expression of genes and create phenotypes that can potentially yield clues about the function of these genes. In the postgenomic era, the elucidation of the physiological function of genes has become the rate-limiting step in the quest to develop 'gene-based drugs' and RNAi could potentially play a pivotal role in the validation of such novel drugs. In this 2005 overview, the basic concepts and applications of RNAi biology are discussed. Leading experts from both academia and industry have contributed to this invaluable reference. The volume is forwarded by Andrew Fire, one of the winners of the 2006 Nobel Prize for the discovery of RNA Interference.
Table of Contents
| Basic RNAi, siRNA and Gene Silencing Mechanisms | |
| RNAi beginnings: overview of the pathway in C. elegans | |
| Dicer in RNAi: its roles in vivo and utility in vitro | |
| Genes required for RNAi | |
| MicroRNAs: a small contribution from worms | |
| miRNAs in the brain and the application of RNAi to neurons; | |
| Design and Synthesis of siRNAs | |
| Design and synthesis of small interfering RNA (siRNA) | |
| Automated design and high throughput synthesis of siRNA | |
| Rational design of siRNAs with the Sfold software | |
| Enzymatic production of siRNAS; | |
| Vector Development and In Vivo, In Vitro and In Ovo Delivery Methods | |
| Six methods of inducing RNAi in mammalian cells | |
| Viral delivery of siRNA | |
| siRNA delivery by lentiviral vectors: design and applications | |
| Liposomal delivery of siRNAs in mice | |
| Chemical modifications to achieve increased stability and sensitive detection of siRNA | |
| RNAi in postimplantation mouse embryos | |
| In ovo RNAi opens new possibilities for functional genomics in vertebrates; | |
| Gene Silencing in Model Organisms | |
| Practical applications of RNAi in C. elegans | |
| Inducible RNAi as a forward genetic tool in Trypanosoma brucei | |
| RNAi gene silencing in yeast | |
| RNA silencing in filamentous fungi: Mucor circinelloides as a model organism | |
| RNAi and gene silencing phenomenon mediated by viral suppressors in plants; | |
| Drug Target Validation | |
| Delivering siRNA in vivo for functional genomics and novel therapeutics | |
| The role of RNAi in drug target validation: application to Hepatitis C | |
| RNAi in the drug discovery process | |
| RNAi: use in the drug discovery process; | |
| Therapeutic and Drug Development | |
| RNAi-mediated silencing of viral gene expression and replication | |
| RNAi in drug development: practical considerations | |
| RNAi for the treatment of liver diseases | |
| RNAi applications in animal systems; | |
| Genome Wide RNAi and High Through-Put Analysis | |
| High through-put RNAi-by-soaking in Caenorhabditis elegans | |
| Tools for integrative genomics: genome-Wide RNAi and expression profiling in Drosophila | |
| Microarray analysis and RNA silencing to determine genes functionally important in Mesothelioma | |
| High through-put RNAi | |
| Generation of highly specific vector-based shRNAi libraries directed against the entire human genome | |
| Table of Contents provided by Publisher. All Rights Reserved. |
An electronic version of this book is available through VitalSource.
This book is viewable on PC, Mac, iPhone, iPad, iPod Touch, and most smartphones.
By purchasing, you will be able to view this book online, as well as download it, for the chosen number of days.
Digital License
You are licensing a digital product for a set duration. Durations are set forth in the product description, with "Lifetime" typically meaning five (5) years of online access and permanent download to a supported device. All licenses are non-transferable.
More details can be found here.
A downloadable version of this book is available through the eCampus Reader or compatible Adobe readers.
Applications are available on iOS, Android, PC, Mac, and Windows Mobile platforms.
Please view the compatibility matrix prior to purchase.